Skip to main content
Top
Published in: Lasers in Medical Science 3/2015

01-04-2015 | Original Article

The bactericidal effect of 470-nm light and hyperbaric oxygen on methicillin-resistant Staphylococcus aureus (MRSA)

Authors: Violet Vakunseh Bumah, Harry Thomas Whelan, Daniela Santos Masson-Meyers, Brendan Quirk, Ellen Buchmann, Chukuka Samuel Enwemeka

Published in: Lasers in Medical Science | Issue 3/2015

Login to get access

Abstract

It has been shown that, in vitro, hyperbaric oxygen (HBO) suppresses 28 % bacterial growth, while 470-nm blue light alone suppresses up to 92 % methicillin-resistant Staphylococcus aureus (MRSA) in one application in vitro. Therefore, we determined if combined 470-nm light (55 J/cm2) and HBO will yield 100 % bacterial suppression in experimental simulation of mild, moderate or severe MRSA infection. We cultured MRSA at 3 × 106, 5 × 106, 7 × 106, 8 × 106, or 12 × 106 CFU/ml and treated each concentration in four groups as follows: (1) control (no treatment) (2) photo-irradiation only, (3) photo-irradiation then HBO, (4) HBO only, and (5) HBO then photo-irradiation. Bacteria colonies were then quantified. The results showed that at each bacterial concentration, HBO alone was significantly less effective in suppressing MRSA than photo-irradiation or combined HBO and photo-irradiation (p < 0.0001). Similarly, at no bacterial concentration did combined HBO and 470-nm light treatment yield a statistically better result than 470-nm light alone (p > 0.05), neither did HBO treatment either before or after irradiation make a difference. Furthermore, at no bacterial concentration was 100 % MRSA suppression achieved. Indeed, the maximum bacterial suppression attained was in the mild infection model (3 × 106 CFU/ml), with blue light producing 97.3 ± 0.2 % suppression and HBO + 55 J/cm2 yielding 97.5 ± 2.5 % suppression. We conclude that (1) HBO and 470-nm light individually suppress MRSA growth; (2) 470-nm blue light is more effective in suppressing MRSA than HBO; and (3) HBO did not act synergistically to heighten the bactericidal effect of 470-nm light.
Literature
1.
go back to reference Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, Coombs GW, Pearman JW, Tenover FC, Kapi M, Tiensasitorn C, Ito T, Hiramatsu K (2002) Dissemination of new methicillin-resistant Staphylococcus aureus clones in communities. J Clin Microbiol 40(11):4289–4294CrossRefPubMedCentralPubMed Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, Coombs GW, Pearman JW, Tenover FC, Kapi M, Tiensasitorn C, Ito T, Hiramatsu K (2002) Dissemination of new methicillin-resistant Staphylococcus aureus clones in communities. J Clin Microbiol 40(11):4289–4294CrossRefPubMedCentralPubMed
2.
go back to reference Moellering RC (2006) The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med 144(5):368–370CrossRefPubMed Moellering RC (2006) The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med 144(5):368–370CrossRefPubMed
3.
go back to reference Bures S, Fishbain JT, Uyehara CFT, Parker JM, Berg BW (2000) Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control 28(6):465–471CrossRefPubMed Bures S, Fishbain JT, Uyehara CFT, Parker JM, Berg BW (2000) Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control 28(6):465–471CrossRefPubMed
4.
go back to reference Graham PL, Lin SX, Larson EL (2006) A US population-based survey of Staphylococcus aureus colonization. Ann Intern Med 144(5):318–325CrossRefPubMed Graham PL, Lin SX, Larson EL (2006) A US population-based survey of Staphylococcus aureus colonization. Ann Intern Med 144(5):318–325CrossRefPubMed
5.
go back to reference Klevens R, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK (2007) Methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15):1763–1771CrossRefPubMed Klevens R, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK (2007) Methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15):1763–1771CrossRefPubMed
7.
go back to reference Mccullough AC, Seifried M, Zhao X, Haase J, Kabat WJ, Yogev R, Blumenthal RM, Mukundan D (2011) Higher incidence of perineal community acquired MRSA infections among toddlers. BMC Pediatr 11:96CrossRefPubMedCentralPubMed Mccullough AC, Seifried M, Zhao X, Haase J, Kabat WJ, Yogev R, Blumenthal RM, Mukundan D (2011) Higher incidence of perineal community acquired MRSA infections among toddlers. BMC Pediatr 11:96CrossRefPubMedCentralPubMed
8.
go back to reference Miu-ling W, Kwok-ming P, Yuen-kong W, Shuk-Kwan C, Lai-key K, Sik-on P (2014) An outbreak of community-associated methicillin-resistant Staphylococcus aureus infection in a boarding school in Hong Kong Special Administrative Region (China). Western Pac Surveill Response J 5(1):1–6CrossRefPubMedCentralPubMed Miu-ling W, Kwok-ming P, Yuen-kong W, Shuk-Kwan C, Lai-key K, Sik-on P (2014) An outbreak of community-associated methicillin-resistant Staphylococcus aureus infection in a boarding school in Hong Kong Special Administrative Region (China). Western Pac Surveill Response J 5(1):1–6CrossRefPubMedCentralPubMed
9.
go back to reference Enwemeka CS (2013) Antimicrobial blue light: an emerging alternative to antibiotics. Photomed Laser Surg 31(11):1–3CrossRef Enwemeka CS (2013) Antimicrobial blue light: an emerging alternative to antibiotics. Photomed Laser Surg 31(11):1–3CrossRef
10.
go back to reference Enwemeka CS, Williams D, Hollosi S, Yens D, Enwemeka SK (2008) Visible 405 nm SLD photo-destroys methicillin resistant Staphylococcus aureus (MRSA) in vitro. Lasers Surg Med 40(10):734–737CrossRefPubMed Enwemeka CS, Williams D, Hollosi S, Yens D, Enwemeka SK (2008) Visible 405 nm SLD photo-destroys methicillin resistant Staphylococcus aureus (MRSA) in vitro. Lasers Surg Med 40(10):734–737CrossRefPubMed
11.
go back to reference Enwemeka CS, Williams D, Hollosi S, Yens D (2008) Blue light photo destroys methicillin resistant Staphylococcus aureus (MRSA) in-vitro. In: Waynant R, Tata D (eds) Lecture notes in electrical Engineering, vol 12. Springer Publishers, New York, pp 3–37 Enwemeka CS, Williams D, Hollosi S, Yens D (2008) Blue light photo destroys methicillin resistant Staphylococcus aureus (MRSA) in-vitro. In: Waynant R, Tata D (eds) Lecture notes in electrical Engineering, vol 12. Springer Publishers, New York, pp 3–37
12.
go back to reference Enwemeka CS, Williams D, Hollosi S, Enwemeka SK, Hollosi S, Yens D (2009) Blue 470-nm light kills methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Photomed Laser Surg 27(2):221–226CrossRefPubMed Enwemeka CS, Williams D, Hollosi S, Enwemeka SK, Hollosi S, Yens D (2009) Blue 470-nm light kills methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Photomed Laser Surg 27(2):221–226CrossRefPubMed
13.
go back to reference Lipovsky A, Nitzen Y, Friedmann H, Lubart R (2009) Sensitivity of Staphylococcus aureus strains to broadband visible light. Photochem Photobiol 85(1):255–260CrossRefPubMed Lipovsky A, Nitzen Y, Friedmann H, Lubart R (2009) Sensitivity of Staphylococcus aureus strains to broadband visible light. Photochem Photobiol 85(1):255–260CrossRefPubMed
14.
go back to reference Dai T, Gupta A, Huang YY, Sherwood ME, Murray CK, Vrahas MS, Kielian T, Hamblin MR (2013) Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomed Laser Surg 31(11):531–538CrossRefPubMedCentralPubMed Dai T, Gupta A, Huang YY, Sherwood ME, Murray CK, Vrahas MS, Kielian T, Hamblin MR (2013) Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomed Laser Surg 31(11):531–538CrossRefPubMedCentralPubMed
15.
go back to reference Bumah VV, Masson-Meyers DS, Cashin SE, Enwemeka CS (2013) Wavelength and bacterial density influence the bactericidal effect of blue light on methicillin-resistant Staphylococcus aureus (MRSA). Photomed Laser Surg 31(11):547–553CrossRefPubMed Bumah VV, Masson-Meyers DS, Cashin SE, Enwemeka CS (2013) Wavelength and bacterial density influence the bactericidal effect of blue light on methicillin-resistant Staphylococcus aureus (MRSA). Photomed Laser Surg 31(11):547–553CrossRefPubMed
16.
go back to reference Maclean M, McKenzie K, Anderson JG, Gettinby G, MacGregor SJ (2014) 405 nm light technology for the inactivation of pathogens and its potential role for environmental disinfection and infection control. J Hosp Infect 88(1):1–11CrossRefPubMed Maclean M, McKenzie K, Anderson JG, Gettinby G, MacGregor SJ (2014) 405 nm light technology for the inactivation of pathogens and its potential role for environmental disinfection and infection control. J Hosp Infect 88(1):1–11CrossRefPubMed
17.
18.
go back to reference Müller P, Alber DG, Turnbull L, Schlothauer RC, Carter DA, Whitchurch CB, Harry EJ (2013) Synergism between Medihoney and Rifampicin against methicillin-resistant Staphylococcus aureus (MRSA). PLoS ONE 8(2):e57679CrossRefPubMedCentralPubMed Müller P, Alber DG, Turnbull L, Schlothauer RC, Carter DA, Whitchurch CB, Harry EJ (2013) Synergism between Medihoney and Rifampicin against methicillin-resistant Staphylococcus aureus (MRSA). PLoS ONE 8(2):e57679CrossRefPubMedCentralPubMed
19.
go back to reference Tsuneyoshi I, Boyle WA III, Kanmura Y, Fujimoto T (2001) Hyperbaric hyperoxia suppresses growth of Staphylococcus aureus, including methicillin-resistant strains. J Anesth 15(1):29–32CrossRefPubMed Tsuneyoshi I, Boyle WA III, Kanmura Y, Fujimoto T (2001) Hyperbaric hyperoxia suppresses growth of Staphylococcus aureus, including methicillin-resistant strains. J Anesth 15(1):29–32CrossRefPubMed
20.
go back to reference Turhan V, Sacar S, Uzun G, Mustafa S, Yildz S, Ceran N, Gorur R, Oncul O (2009) Hyperbaric oxygen as adjunctive therapy in experimental mediastinitis. J Surg Res 155(1):111–115CrossRefPubMed Turhan V, Sacar S, Uzun G, Mustafa S, Yildz S, Ceran N, Gorur R, Oncul O (2009) Hyperbaric oxygen as adjunctive therapy in experimental mediastinitis. J Surg Res 155(1):111–115CrossRefPubMed
21.
go back to reference Gu N, Nagatomo F, Fujino H, Takeda I, Tsuda K, Ishihara A (2010) Hyperbaric oxygen exposure improves blood glucose level and muscle oxidative capacity in rats with type 2 diabetes. Diabetes Technol Ther 12(2):125–133CrossRefPubMed Gu N, Nagatomo F, Fujino H, Takeda I, Tsuda K, Ishihara A (2010) Hyperbaric oxygen exposure improves blood glucose level and muscle oxidative capacity in rats with type 2 diabetes. Diabetes Technol Ther 12(2):125–133CrossRefPubMed
22.
go back to reference Novaleski C (2009) Does hyperbaric oxygenation therapy benefit in the treatment of non-healing wounds in diabetic patients? Internet J Acad Physician Assist 6(2):4 Novaleski C (2009) Does hyperbaric oxygenation therapy benefit in the treatment of non-healing wounds in diabetic patients? Internet J Acad Physician Assist 6(2):4
23.
go back to reference Michalski D, Hartig W, Schneider D, Hobohm C (2011) Use of normobaric and hyperbaric oxygen in acute focal cerebral ischemia - a preclinical and clinical review. Acta Neurol Scand 123(2):85–97CrossRefPubMed Michalski D, Hartig W, Schneider D, Hobohm C (2011) Use of normobaric and hyperbaric oxygen in acute focal cerebral ischemia - a preclinical and clinical review. Acta Neurol Scand 123(2):85–97CrossRefPubMed
24.
go back to reference Fischer BR, Palkovic S, Holling M, Wölfer J, Wassmann H (2010) Rationale of hyperbaric oxygenation in cerebral vascular insult. Curr Vasc Pharmacol 8(1):35–43CrossRefPubMed Fischer BR, Palkovic S, Holling M, Wölfer J, Wassmann H (2010) Rationale of hyperbaric oxygenation in cerebral vascular insult. Curr Vasc Pharmacol 8(1):35–43CrossRefPubMed
25.
go back to reference Zhao B, Meng LX, Ding YY, Cao YY (2014) Hyperbaric oxygen treatment produces an antinociceptive response phase and inhibits astrocyte activation and inflammatory response in a rat model of neuropathic pain. J Mol Neurosci 53(2):251–261CrossRefPubMed Zhao B, Meng LX, Ding YY, Cao YY (2014) Hyperbaric oxygen treatment produces an antinociceptive response phase and inhibits astrocyte activation and inflammatory response in a rat model of neuropathic pain. J Mol Neurosci 53(2):251–261CrossRefPubMed
26.
go back to reference Whelan HT, Niezgoda JA, Kindwall EP, Cabigas B, Lewis MC (2006) Hyperbaric oxygenation. In: Webster JG (ed) Encyclopedia of medical devices and instrumentation, vol 4, 2nd edn. Wiley-Interscience, Hoboken, pp 29–33 Whelan HT, Niezgoda JA, Kindwall EP, Cabigas B, Lewis MC (2006) Hyperbaric oxygenation. In: Webster JG (ed) Encyclopedia of medical devices and instrumentation, vol 4, 2nd edn. Wiley-Interscience, Hoboken, pp 29–33
27.
go back to reference Dennog C, Hartmann A, Frey G, Speit G (1996) Detection of DNA damage after hyperbaric oxygen (HBO) therapy. Mutagenesis 11(6):605–609CrossRefPubMed Dennog C, Hartmann A, Frey G, Speit G (1996) Detection of DNA damage after hyperbaric oxygen (HBO) therapy. Mutagenesis 11(6):605–609CrossRefPubMed
28.
go back to reference Shandley S, Prato-Matthews K, Cox J, Abplanalp A, Romano D, Kalns J, Michaelson R (2010) Efficacy of hyperbaric oxygen therapy in a mouse model of implant-associated osteomyelitis. J Orthop Res 30(2):203–208CrossRef Shandley S, Prato-Matthews K, Cox J, Abplanalp A, Romano D, Kalns J, Michaelson R (2010) Efficacy of hyperbaric oxygen therapy in a mouse model of implant-associated osteomyelitis. J Orthop Res 30(2):203–208CrossRef
29.
go back to reference Maclean M, MacGregor SJ, Anderson JG, Woolsey GA (2009) Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array. Appl Environ Microbiol 75(7):1932–1937CrossRefPubMedCentralPubMed Maclean M, MacGregor SJ, Anderson JG, Woolsey GA (2009) Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array. Appl Environ Microbiol 75(7):1932–1937CrossRefPubMedCentralPubMed
30.
go back to reference Ardic N, Yildiz S, Cimsit M, Turhan V, Ozyurt M, Haznederoglu T (2006) The effect of hyperbaric oxygenation on the in vitro growth of Escherichia coli in environments with and without blood cells. Ann Microbiol 56(1):77–79CrossRef Ardic N, Yildiz S, Cimsit M, Turhan V, Ozyurt M, Haznederoglu T (2006) The effect of hyperbaric oxygenation on the in vitro growth of Escherichia coli in environments with and without blood cells. Ann Microbiol 56(1):77–79CrossRef
31.
go back to reference Tally FP, Sullivan CE (1981) Metronidazole: in vitro activity, pharmacology and efficacy in anaerobic bacterial infections. Pharmacotherapy 1(1):28–38PubMed Tally FP, Sullivan CE (1981) Metronidazole: in vitro activity, pharmacology and efficacy in anaerobic bacterial infections. Pharmacotherapy 1(1):28–38PubMed
32.
go back to reference Jamieson D, Chance B, Cadenas E, Bovens A (1986) The relation of free radical production to hyperoxia. Annu Rev Physiol 48:703–719CrossRefPubMed Jamieson D, Chance B, Cadenas E, Bovens A (1986) The relation of free radical production to hyperoxia. Annu Rev Physiol 48:703–719CrossRefPubMed
33.
go back to reference Park MK, Muhvich KH, Myers RAM, Marzella L (2004) Effects of hyperbaric oxygen in infectious diseases: basic mechanisms. In: Kindwall EP, Whelan HT (eds) Hyperbaric Medicine Practice. Best Publishing, Flagstaff, pp 141–172 Park MK, Muhvich KH, Myers RAM, Marzella L (2004) Effects of hyperbaric oxygen in infectious diseases: basic mechanisms. In: Kindwall EP, Whelan HT (eds) Hyperbaric Medicine Practice. Best Publishing, Flagstaff, pp 141–172
34.
go back to reference Cimşit M, Uzun G, Yildiz S (2009) Hyperbaric oxygen therapy as an anti-infective agent. Expert Rev Anti-Infect Ther 7(8):1015–1026CrossRefPubMed Cimşit M, Uzun G, Yildiz S (2009) Hyperbaric oxygen therapy as an anti-infective agent. Expert Rev Anti-Infect Ther 7(8):1015–1026CrossRefPubMed
35.
go back to reference Hamblin MR, Demidova TN (2006) Mechanisms of low level light therapy – an introduction. In: Hamblin MR, Anders JJ, Waynant RW (eds) Mechanisms for low-light therapy. Proceedings of the International Society for Optical Engineering, vol 6140, Bellingham, p 1–12 Hamblin MR, Demidova TN (2006) Mechanisms of low level light therapy – an introduction. In: Hamblin MR, Anders JJ, Waynant RW (eds) Mechanisms for low-light therapy. Proceedings of the International Society for Optical Engineering, vol 6140, Bellingham, p 1–12
36.
go back to reference Maclean M, Macgregor SJ, Anderson JG, Woolsey GA (2008) The role of oxygen in the visible-light inactivation of Staphylococcus aureus. J Photochem Photobiol B 92(3):180–184CrossRefPubMed Maclean M, Macgregor SJ, Anderson JG, Woolsey GA (2008) The role of oxygen in the visible-light inactivation of Staphylococcus aureus. J Photochem Photobiol B 92(3):180–184CrossRefPubMed
37.
go back to reference Udo EE, Pearman JW, Brubb WB (1993) Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 25(2):97–108CrossRefPubMed Udo EE, Pearman JW, Brubb WB (1993) Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 25(2):97–108CrossRefPubMed
38.
go back to reference Jarvis WR, Jarvis AA, Chinn RY (2010) National prevalence of methicillin resistant Staphylococcus aureus in inpatients at the United States health care facilities. Am J Infect Control 40(3):194–200CrossRef Jarvis WR, Jarvis AA, Chinn RY (2010) National prevalence of methicillin resistant Staphylococcus aureus in inpatients at the United States health care facilities. Am J Infect Control 40(3):194–200CrossRef
39.
go back to reference Miller LG, Diep BA (2008) Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46(5):752–760CrossRefPubMed Miller LG, Diep BA (2008) Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46(5):752–760CrossRefPubMed
40.
go back to reference Li M, Diep BA, Villaruza AE, Braughtona KR, Jiang X, DeLeoa FR, Chambers HF, Lub Y, Otto M (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 106(14):5883–5888CrossRefPubMedCentralPubMed Li M, Diep BA, Villaruza AE, Braughtona KR, Jiang X, DeLeoa FR, Chambers HF, Lub Y, Otto M (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 106(14):5883–5888CrossRefPubMedCentralPubMed
41.
go back to reference Tenover FC, McDougal LK, Goering RV, Killgore G, Projan SJ, Patel JB, Dunman PM (2006) Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 44(1):108–118CrossRefPubMedCentralPubMed Tenover FC, McDougal LK, Goering RV, Killgore G, Projan SJ, Patel JB, Dunman PM (2006) Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 44(1):108–118CrossRefPubMedCentralPubMed
Metadata
Title
The bactericidal effect of 470-nm light and hyperbaric oxygen on methicillin-resistant Staphylococcus aureus (MRSA)
Authors
Violet Vakunseh Bumah
Harry Thomas Whelan
Daniela Santos Masson-Meyers
Brendan Quirk
Ellen Buchmann
Chukuka Samuel Enwemeka
Publication date
01-04-2015
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 3/2015
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-015-1722-9

Other articles of this Issue 3/2015

Lasers in Medical Science 3/2015 Go to the issue